Article info
PDFOriginal article
AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis
- Correspondence to Dr Yu Honggang, Department of Gastroenterology, Renmin Hospital of Wuhan University, Institute for Gastroenterology and Hepatology, Wuhan University, Jiefang Road 238, Wuhan 430060, Hubei Province, China; yhg_rmhwh{at}163.com
Citation
AGXT2L1 is down-regulated in heptocellular carcinoma and associated with abnormal lipogenesis
Publication history
- Received March 27, 2015
- Revised June 22, 2015
- Accepted July 30, 2015
- First published August 20, 2015.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/